Abstract
Two in vitro passages of a human endometrial adenocarcinoma continuous cell line (RL95-2), an early (subcultured less than 30 times) and a late passage (subcultured greater than 200 times) have provided an interesting model to study the growth, morphologic, and invasive properties of endometrial tumors. The early passage, which has been shown to be estrogen-receptor positive, has characteristics closely resembling a primary tumor, whereas the estrogen receptor negative late passage exhibits several features of the metastatic phenotype. Compared to the early passage cells, the late passage cells were less serum dependent, formed foci, demonstrated a faster rate of growth (due to their shorter doubling times), and attained higher saturation densities. The late passage cells also displayed an altered morphology which was accompanied by alterations in the distribution of F-actin. Even though early and late passages showed similar invasive potential in an in vitro invasion assay, the late passage cells, by virtue of their several transformed characteristics, maintain distinctive properties compared with their early passage counterparts.
MeSH Terms
Actins/analysis
Adenocarcinoma/pathology,ultrastructure
Cell Division
Culture Media
Endometrial Neoplasms/pathology,ultrastructure
Female
Humans
Neoplasm Invasiveness/pathology
Neoplasm Metastasis/pathology
Tumor Cells, Cultured/drug effects,ultrastructure
Chemicals
Actins
Culture Media
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Sundareshan P
Department of Anatomy, College of Medicine, University of Arizona, Tucson 85724.
Hendrix M J
References (31)
31 references, click to expand
-
Mitogenic action of oestradiol-17 beta on human myometrial and endometrial cells in long-term tissue cultures.
J Endocrinol. 1973 Oct;59(1):87-97
PMID: 4748531
-
Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line.
Cancer Res. 1987 Sep 15;47(18):4909-14
PMID: 3497713
-
Membrane invasion culture system (MICS).
Med Instrum. 1984 Sep-Oct;18(5):268-71
PMID: 6493100
-
Tumor heterogeneity.
Cancer Res. 1984 Jun;44(6):2259-65
PMID: 6372991
-
Development and characterization of established cell lines from primary and metastatic regions of human endometrial adenocarcinoma.
Cancer Res. 1977 Jun;37(6):1777-85
PMID: 858140
-
Human endometrial cells in primary tissue culture: estrogen interactions and modulation of cell proliferation.
J Clin Endocrinol Metab. 1978 Aug;47(2):333-44
PMID: 263301
-
Establishment and characterization of a new endometrial cancer cell line (SCRC-1).
Am J Obstet Gynecol. 1979 Nov 1;135(5):671-9
PMID: 228555
-
The cytoskeleton in cancer cells.
Biochim Biophys Acta. 1985;780(3):197-212
PMID: 3896312
-
A simple quantitative assay for studying the invasive potential of high and low human metastatic variants.
Cancer Lett. 1987 Dec;38(1-2):137-47
PMID: 3690504
-
Current concepts in the control of carcinoma of the endometrium.
CA Cancer J Clin. 1986 Jul-Aug;36(4):245-53
PMID: 3089546
-
Cellular heterogeneity in malignant neoplasms and the therapy of metastases.
Ann N Y Acad Sci. 1982 Dec 10;397:34-48
PMID: 6961847
-
Isolation and culture of human endometrial glands.
J Clin Endocrinol Metab. 1979 Apr;48(4):639-41
PMID: 429509
-
Motility and adhesive properties of high- and low-metastatic murine neoplastic cells.
Cancer Res. 1984 Feb;44(2):811-24
PMID: 6692379
-
Comparison of tumor cell invasion assays: human amnion versus reconstituted basement membrane barriers.
Invasion Metastasis. 1989;9(5):278-97
PMID: 2767926
-
Epidermal growth factor inhibits the proliferation of a human endometrial carcinoma cell line.
J Clin Endocrinol Metab. 1986 May;62(5):874-80
PMID: 3007558
-
Loss of transplantability and induction of immunoprotection by mouse ascites tumor cells in tissue culture.
Proc Soc Exp Biol Med. 1970 May;134(1):305-8
PMID: 5423517
-
[Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors].
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Jul;37(7):1103-11
PMID: 4031568
-
Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.
Cancer Res. 1986 Jan;46(1):1-7
PMID: 2998604
-
Tumor heterogeneity and the biology of cancer invasion and metastasis.
Cancer Res. 1978 Sep;38(9):2651-60
PMID: 354778
-
Effects of epidermal growth factor on growth response, morphology, and invasive potential of human endometrial carcinoma cell line RL95-2.
Cancer Commun. 1991 May;3(5):149-58
PMID: 1904255
-
ETN-1: a new human endometrial carcinoma cell line producing ascites and distant metastases in nude mice.
Int J Cancer. 1989 Jun 15;43(6):1098-103
PMID: 2732002
-
Establishment and characterization of the cell-line of a human edometrial adenoacanthoma.
Eur J Cancer. 1977 Mar 29;13(3):253-9
PMID: 862644
-
Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture.
In Vitro. 1983 Mar;19(3 Pt 1):147-58
PMID: 6339371
-
Phenotypic stability of murine tumor cells in vitro and in vivo.
J Natl Cancer Inst. 1982 Jun;68(6):957-62
PMID: 6953274
-
Establishment of a cell line of human endometrial adenocarcinoma in vitro.
Am J Obstet Gynecol. 1972 Dec 15;114(8):1012-9
PMID: 4673779
-
Implications of tumor progression on clinical oncology.
Clin Exp Metastasis. 1985 Jul-Sep;3(3):151-88
PMID: 3902300
-
Actin cytoskeletal organization loss in the benign-to-malignant tumor transition in cultured human colonic epithelial cells.
Cancer Res. 1984 Jul;44(7):3040-50
PMID: 6722823
-
Generation of phenotypic diversity and progression in metastatic tumor cells.
Cancer Metastasis Rev. 1984;3(1):25-42
PMID: 6370418
-
Tumor angiogenesis.
Adv Cancer Res. 1985;43:175-203
PMID: 2581424
-
UM-EC-1, a new hypodiploid human cell line derived from a poorly differentiated endometrial cancer.
Cancer Res. 1988 Apr 1;48(7):1864-73
PMID: 3349465
-
Phenotypic drift of metastatic and cell-surface properties of mammary adenocarcinoma cell clones during growth in vitro.
Int J Cancer. 1981 Dec;28(6):731-8
PMID: 7037655